Comparison of male breast cancer in China and the US: a real-world cohort study
The disparities in characteristics and treatment between Chinese and American MBC patients were demonstrated. Chinese patients tended to receive more aggressive surgery as well as chemotherapy and present with different OS even after adjustments.
Authors
- Guolin Ye (ORCID: https://orcid.org/0000-0003-3592-4265)
- Hebing Wang (ORCID: https://orcid.org/0000-0001-5311-5379)
- Ying Lin (ORCID: https://orcid.org/0000-0002-4321-0695)
- Li Ma (ORCID: https://orcid.org/0000-0002-5444-5262)
- Jianyun Nie (ORCID: https://orcid.org/0000-0003-4573-2793)
- Yuxuan Gao (ORCID: https://orcid.org/0000-0003-4512-4851)
- Mengmeng Zhang (ORCID: https://orcid.org/0009-0007-6032-6896)
- Gang Sun (ORCID: https://orcid.org/0000-0002-7804-1967)
- Zefei Jiang
Institutions
- Hebei Medical University (CN)
- Fujian Medical University (CN)
- Xinjiang Medical University (CN)
- Sun Yat-sen University (CN)
- Kunming Medical University (CN)
- Chinese PLA General Hospital (CN)
- First People's Hospital of Foshan (CN)
- Fourth Hospital of Hebei Medical University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Sanming University (CN)
Publication Details
- Journal
- Translational Breast Cancer Research
- Published
- 2026-01-01
- DOI
- https://doi.org/10.21037/tbcr-25-24
- Primary Topic
- Male Breast Health Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00